12 years experience. Solid planning, organizational skills in coordinating projects, budgets, forecasts. See the big picture, plan appropriate strategies to achieve results. Successful team builder who encourages idea generation and project completion, maintaining an energetic, fun work environment. International experience. |
FINANCE DIRECTOR
Results-oriented Finance Director with MBA and 12 years of finance and public accounting experience. Solid planning and organizational skills in coordinating projects, budgets and forecasts. Sees the big picture and plans appropriate strategies to achieve results. Quickly grasps concepts, analyzes, and interprets ideas into action. Successful team builder and facilitator, creates an atmosphere that encourages idea generation and project completion while maintaining an energetic, fun work environment. Proven ability to manage multiple assignments efficiently. International experience. Comprehensive experience includes:
Reporting/Documentation Financial Management/Analysis General Accounting
Staff Management GAAP Public Accounting
Budget/Forecast Development and Documentation Business Analysis Systems Implementation
Working Knowledge of Hyperion Expert in Global Concur Expense Rollout Expert in Excel
EXPERIENCE
1999-2007 PFIZER INC New York, NY
2007 Specialty Business Unit
Finance Director Anti-Infectives 2007
Create and administer full income statement for Pfizers Anti-Infective product grouping, including $900M in revenues with net income of $674M.
Developed a creative price increase structure over two anti-infective products reduced pricing pressure on one product while bringing in an additional $350K revenue.
Deliver ongoing formal training related to proprietary systems, Travel and Entertainment policy, and compliance with healthcare law and Sarbanes-Oxley.
Summarize relevant financial data and present it to members of the sales and marketing leadership teams.
Design and communicate workable initiatives and solutions for managing the business, including contracting ideas and improving the current revenue model.
2005-2007 U.S. Pharmaceuticals Sales Finance
Finance Director 2007
Senior Finance Manager/Team Leader 2005-2006
Evaluated budgetary impact of headcount reduction across a 10,000 member field force, including both the costs and savings related to the reduction. Supervised a team of three people.
Oversaw the roll-out of a new Travel and Entertainment expense system to over 10,000 sales force colleagues. Built needs analysis, developed and launched web-based training for the system, handled technology issues, created all communications related to the launch of the new system, and presented live training to 500 colleagues.
Analyzed data to determine feasibility and appropriateness of hiring an outside field force to promote a specific product.
Supervised summer associate; responsibilities included creating projects, developing work plan, and providing periodic informal and formal feedback.
Developed and reported on budget and forecast of $14M.
Active member of team developing and rolling out a new global budgeting and forecasting system.
Relationship Manager for NYU Corporate Finance Recruiting Team.
2001-2005 Pfizer Global Pharmaceuticals Medical Finance
Senior Finance Manager/Team Leader 2005
Senior Finance Manager 2003-2005
Finance Manager 2001-2003
Managed team of two Senior Finance Managers and one Finance Manager. Responsible for all aspects of development planning, project planning and assignment, and for ensuring superior service to internal customers.
Built budgets with medical teams for Pfizer-developed and co-promoted products using multiple in-house systems. Evaluated individual project budgets vs. actual life-to-date spending and forecasted spending to determine areas of opportunity for additional projects.
Accountable for therapeutic class with $150 million medical budget.
Designed operating plan document language, generated appropriate interim and final due dates for budget data, and determined which colleagues should be involved in each process as an active participant in both the 2005 Operating Plan Task Force and the 2005 Worldwide Strategic Clinical Operating Plan Task Force.
Created and presented ad hoc presentations as requested by individual medical teams.
Developed a training program for forecasting processes and proprietary departmental forms and presented it to all clinical study managers across all teams.
Directed a team of three people as Team Lead for business school recruiting, and organized all second round interviewing schedules for all students invited. Coordinated and led all rating meetings where candidates were selected for hire.
1999- 2001 Corporate Finance Rotational Program
Business Analyst
Highly selective management development program comprised of 5-7 MBA program graduates chosen to rotate through four distinct Finance departments over the course of two years.
Pfizer Global Pharmaceuticals Medical Finance 2001
Performed an analysis on a Pfizer product which was facing generic competition.
Created a process for reporting vendor spending information to senior management.
Benefit Financing, Treasury 2000
Performed investment manager rationalization study involving the pooling of two pension plans. Analyzed characteristics of both plans portfolios for possible overlaps.
Conducted asset allocation studies to determine in which investment categories (broad and narrow) the Pfizer Retirement Annuity Plan should be invested. Analyzed the appropriateness of investing in single assets and the impact it would have on the plan in terms of risk and return.
Financial Services Europe-Belgium 2000
Assembled, tested, and reviewed monthly forecasts for foreign exchange hedging for 20 markets. Submitted hedge and revision orders to treasury center. Analyzed impact of hedge orders on balance sheet and income statement.
Developed a hedge revision process in order to make month-end hedges more accurate. Documented processes and workflows detailing the forecasting procedures.
Pfizer Global Pharmaceuticals Pricing 1999
Analyzed antibiotic prices across major Asian and African markets to determine if it was appropriate to change pricing strategy for a Pfizer product while maintaining or gaining market share.
Analyzed different pricing strategies for product preparing to launch based on competitors strategies. Created several scenarios and assisted in presenting them to members of product team. Determined whether prices could be adjusted for Pfizer products as a major generic producer prepared to launch generic versions in Hungarian market.
Summer 1998 Global Financial Systems Support
Corporate Finance Summer Associate
Researched and analyzed the financial effects on Pfizer of the anticipated currency change in the European Community. Summarized findings in a detailed document and provided biweekly updates.
Investigated the current financial systems in use at seven U.S. plants by interviewing personnel at each location. Created a requirements/gap analysis detailing the needs of each plant against the features offered by the companys software vendor. Analyzed the impact of converting from outdated fixed assets financial systems to a common platform. Initiated and completed the first phase of the conversion process.
1993-1997 ERNST & YOUNG LLP Detroit, MI
Senior Auditor
Led teams in the design and implementation of audits of financial services, insurance, manufacturing, and health care companies.
Reengineered audit process to increase revenues realized on client engagements by reducing hours worked and expenses incurred while maintaining a consistent level of service.
EDUCATION
NEW YORK UNIVERSITY New York, NY
Leonard N. Stern School of Business
Master of Business Administration, Emphasis in Finance/Information Systems, 1999
UNIVERSITY OF MICHIGAN Ann Arbor, MI
School of Business Administration
Bachelor of Business Administration, Concentration in Accounting, 1993 |
